Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02268370
Title Treatment-free Remission Accomplished With Dasatinib in Patients With CML (TRAD)
Acronym TRAD
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult
Covered Countries CAN


No variant requirements are available.